Entering text into the input field will update the search result below

Wave Life Sciences GAAP EPS of -$0.61 misses by $0.06, revenue of $1.76M misses by $11.98M

Mar. 03, 2022 7:34 AM ETWave Life Sciences Ltd. (WVE) StockBy: Urvi Shah, SA News Editor
  • Wave Life Sciences press release (NASDAQ:WVE): Q4 GAAP EPS of -$0.61 misses by $0.06.
  • Revenue of $1.76M (-81.4% Y/Y) misses by $11.98M.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About WVE

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Wave Life Sciences Ltd.
Theravance Biopharma, Inc.
TerrAscend Corp.
AN2 Therapeutics, Inc.
Evolus, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.